CRISPR Therapeutics AG

Biological Products, (No Diagnostic Substances)·ZUG·FY end 12/31·CIK 1674416

Board of Directors

11 members · 10 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Samarth Kulkarni, Ph.D.	CEO and Director	—	—	—	—	—
Ali Behbahani, M.D.	Director	—	—	Comp		$357,354
Maria Fardis, Ph.D.	Director	—	—	Audit		$352,168
H. Edward Fleming, Jr., M.D.	Director	—	—	Comp		$343,354
Simeon J. George, M.D.	Director	—	—	—		$342,168
John T. Greene	Director	—	—	AuditComp		$363,917
Katherine A. High, M.D.	Director	—	—	—		$358,123
Sandesh Mahatme, LL.M.	Director	—	—	Audit		$353,127
Briggs W. Morrison, M.D.	Director	0y	—	Comp		$341,069
Christian Rommel, Ph.D.	Director	1y	—	—		$335,740
Douglas A. Treco, Ph.D.	Lead Independent Director	5y	—	Audit		$370,740

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.